Taken together, all these data show that serum CypA plays a significant role in the pathogenesis of colorectal cancer, representing a potential negative prognostic factor for CRC patients treated with bevacizumab and chemotherapy, but also a promising target for advancing the cancer treatment strategies. The gene discussed is PPIA; the disease is cancer.